LS
Leelyn Smith Portfolio holdings
AUM
$610M
This Quarter Return
+6.37%
1 Year Return
+13.61%
3 Year Return
+56.17%
5 Year Return
+93.44%
10 Year Return
–
AUM
$336M
AUM Growth
+$336M
(+7.4%)
Cap. Flow
+$14.8M
Cap. Flow
% of AUM
4.41%
Top 10 Holdings %
Top 10 Hldgs %
40.79%
Holding
399
New
32
Increased
145
Reduced
77
Closed
9
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$2.54M |
| 2 |
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
|
$1.99M |
| 3 |
Merck
MRK
|
$1.96M |
| 4 |
Alibaba
BABA
|
$1.75M |
| 5 |
ARK Innovation ETF
ARKK
|
$1.48M |
Top Sells
| 1 |
Charles Schwab
SCHW
|
$2.16M |
| 2 |
RTX Corp
RTX
|
$1.75M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$1.22M |
| 4 |
First Trust Cloud Computing ETF
SKYY
|
$836K |
| 5 |
First Trust NASDAQ-100 Equal Weighted Index Fund
QQEW
|
$823K |
Sector Composition
| 1 | Technology | 10.61% |
| 2 | Healthcare | 7.68% |
| 3 | Consumer Discretionary | 7.22% |
| 4 | Financials | 5.18% |
| 5 | Consumer Staples | 5.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Invesco QQQ Trust
QQQ
$364B
| $3M | 0.89% |
9,401
+7,967
| +556% | +$2.54M |
|
27
Mastercard
MA
$536B
| $2.88M | 0.86% |
8,085
+347
| +4% | +$124K |
|
28
Analog Devices
ADI
$120B
| $2.82M | 0.84% |
18,183
+806
| +5% | +$125K |
|
29
UnitedHealth
UNH
$279B
| $2.81M | 0.84% |
7,549
-10
| -0.1% | -$3.72K |
|
|
WBA
30
DELISTED
Walgreens Boots Alliance
WBA
| $2.79M | 0.83% |
50,810
+1,292
| +3% | +$70.9K |
|
31
Comcast
CMCSA
$125B
| $2.77M | 0.82% |
51,210
+15,629
| +44% | +$846K |
|
32
Honeywell
HON
$136B
| $2.76M | 0.82% |
12,730
+709
| +6% | +$154K |
|
33
Exxon Mobil
XOM
$477B
| $2.75M | 0.82% |
49,196
+137
| +0.3% | +$7.65K |
|
34
Nike
NKE
$110B
| $2.68M | 0.8% |
20,159
+781
| +4% | +$104K |
|
35
Walmart
WMT
$793B
| $2.56M | 0.76% |
18,856
+993
| +6% | +$135K |
|
36
Eli Lilly
LLY
$661B
| $2.45M | 0.73% |
13,137
+1,019
| +8% | +$190K |
|
37
AbbVie
ABBV
$374B
| $2.44M | 0.73% |
22,506
+754
| +3% | +$81.6K |
|
38
General Dynamics
GD
$86.8B
| $2.38M | 0.71% |
13,119
+1,126
| +9% | +$204K |
|
39
AT&T
T
$208B
| $2.36M | 0.7% |
78,033
+6,082
| +8% | +$184K |
|
40
Intel
INTC
$105B
| $2.3M | 0.68% |
35,871
+1,155
| +3% | +$73.9K |
|
41
Stryker
SYK
$149B
| $2.24M | 0.67% |
9,177
+624
| +7% | +$152K |
|
42
Procter & Gamble
PG
$370B
| $2.17M | 0.65% |
16,042
+516
| +3% | +$69.9K |
|
|
43
Merck
MRK
$210B
| $2.15M | 0.64% |
27,919
+25,370
| +995% | +$1.96M |
|
44
Johnson & Johnson
JNJ
$429B
| $2.13M | 0.63% |
12,927
+551
| +4% | +$90.6K |
|
45
Biogen
BIIB
$20.8B
| $2.12M | 0.63% |
7,561
+345
| +5% | +$96.5K |
|
46
T Rowe Price
TROW
$23.2B
| $2.1M | 0.62% |
12,212
+511
| +4% | +$87.7K |
|
47
Sysco
SYY
$38.8B
| $2.05M | 0.61% |
26,032
+1,123
| +5% | +$88.4K |
|
48
Bristol-Myers Squibb
BMY
$96.7B
| $2.03M | 0.6% |
32,157
+878
| +3% | +$55.4K |
|
49
Altria Group
MO
$112B
| $2.02M | 0.6% |
39,474
+2,746
| +7% | +$140K |
|
50
Coca-Cola
KO
$297B
| $1.98M | 0.59% |
37,610
+2,350
| +7% | +$124K |
|